FOXO board authorizes reverse stock split of up to 1-for-1,000 for Nasdaq or NYSE American uplisting

• Board acted by unanimous written consent on Aug. 13, 2026 to pursue a reverse stock split tied to an exchange uplisting.
• Certificate amendment would allow a reverse split ratio from 1-for-50 to 1-for-1,000, effective only if the board proceeds.
• Majority shareholder Rennova Health delivered written consent on Aug. 13, 2026, representing about 99.12% of voting power.
• Board set a deadline of June 30, 2027 to file the amendment, subject to FINRA processing and board discretion.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-039857), on August 24, 2026, and is solely responsible for the information contained therein.